Mouse CD4 CTLs have been described predominantly in adoptive transfer models and occasionally syngeneic tumor models following CTLA4 blockade, OX40 costimulation, 4-1BB costimulation combined with a tumor vaccine, or tumor-targeted expression of highly immunogenic tetanus toxoid protein (TT)27–32. This evidence concerns the gene CD4 and neoplasm.